Literature DB >> 33948873

Derivation of Multipotent Neural Progenitors from Human Embryonic Stem Cells for Cell Therapy and Biomedical Applications.

Loriana Vitillo1,2, Ludovic Vallier3.   

Abstract

Long-term neuroepithelial-like stem cells (lt-NES) derived from human embryonic stem cells are a stable self-renewing progenitor population with high neurogenic potential and phenotypic plasticity. Lt-NES are amenable to regional patterning toward neurons and glia subtypes and thus represent a valuable source of cells for many biomedical applications. For use in regenerative medicine and cell therapy, lt-NES and their progeny require derivation with high-quality culture conditions suitable for clinical use. In this chapter, we describe a robust method to derive multipotent and expandable lt-NES based on good manufacturing practice and cell therapy-grade reagents. We further describe fully defined protocols to terminally differentiate lt-NES toward GABA-ergic, dopaminergic, and motor neurons.
© 2021. Springer Science+Business Media, LLC.

Entities:  

Keywords:  Cell therapy; Differentiation; GMP; Human embryonic stem cells; Lt-NES; Neural progenitors; Regenerative medicine; Stem cells

Mesh:

Year:  2022        PMID: 33948873     DOI: 10.1007/7651_2021_401

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  Human embryonic stem cells.

Authors:  A Trounson; M Pera
Journal:  Fertil Steril       Date:  2001-10       Impact factor: 7.329

Review 2.  Advances in stem cell research and therapeutic development.

Authors:  Michele De Luca; Alessandro Aiuti; Giulio Cossu; Malin Parmar; Graziella Pellegrini; Pamela Gehron Robey
Journal:  Nat Cell Biol       Date:  2019-06-17       Impact factor: 28.824

3.  A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration.

Authors:  Philipp Koch; Thoralf Opitz; Julius A Steinbeck; Julia Ladewig; Oliver Brüstle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

4.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

Review 5.  Opinion: neural stem cell therapy for neurological diseases: dreams and reality.

Authors:  Ferdinando Rossi; Elena Cattaneo
Journal:  Nat Rev Neurosci       Date:  2002-05       Impact factor: 34.870

6.  Stem cells expanded from the human embryonic hindbrain stably retain regional specification and high neurogenic potency.

Authors:  Jignesh Tailor; Raja Kittappa; Ketty Leto; Monte Gates; Melodie Borel; Ole Paulsen; Sonia Spitzer; Ragnhildur Thora Karadottir; Ferdinando Rossi; Anna Falk; Austin Smith
Journal:  J Neurosci       Date:  2013-07-24       Impact factor: 6.167

7.  Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons.

Authors:  Anna Falk; Philipp Koch; Jaideep Kesavan; Yasuhiro Takashima; Julia Ladewig; Michael Alexander; Ole Wiskow; Jignesh Tailor; Matthew Trotter; Steven Pollard; Austin Smith; Oliver Brüstle
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

Review 8.  Nestin-expressing progenitor cells: function, identity and therapeutic implications.

Authors:  Aurora Bernal; Lorena Arranz
Journal:  Cell Mol Life Sci       Date:  2018-03-14       Impact factor: 9.261

9.  Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis.

Authors:  Julia Deinsberger; David Reisinger; Benedikt Weber
Journal:  NPJ Regen Med       Date:  2020-09-11

10.  Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.

Authors:  Roger A Barker; Malin Parmar; Lorenz Studer; Jun Takahashi
Journal:  Cell Stem Cell       Date:  2017-11-02       Impact factor: 24.633

View more
  1 in total

1.  Xeno-free induced pluripotent stem cell-derived neural progenitor cells for in vivo applications.

Authors:  Ruslan Rust; Rebecca Z Weber; Melanie Generali; Debora Kehl; Chantal Bodenmann; Daniela Uhr; Debora Wanner; Kathrin J Zürcher; Hirohide Saito; Simon P Hoerstrup; Roger M Nitsch; Christian Tackenberg
Journal:  J Transl Med       Date:  2022-09-16       Impact factor: 8.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.